Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With Prediabetes

NCT04131582 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Prediabetic State
Insulin Resistance

Interventions

COMBINATION_PRODUCT: Linagliptin + metformin and Empagliflozin + metformin
DRUG: Metformin

Sponsor

Universidad de Guanajuato

Collaborators

[object Object]